Trials / Terminated
TerminatedNCT02448550
Comparison of Anticoagulation for All-comers Undergoing Percutaneous Coronary Revascularization Trial
Comparison of Unfractionated Heparin and Bivalirudin for Percutaneous Coronary Intervention for Stable Angina, Unstable Angina, and Non-ST Segment Elevation Myocardial Infarction
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 250 (actual)
- Sponsor
- Kaiser Permanente · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to determine whether bivalirudin is non-inferior to unfractionated heparin in patients with stable angina, unstable angina, or non-ST segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bivalirudin | |
| DRUG | Unfractionated heparin |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2016-05-06
- Completion
- 2016-06-16
- First posted
- 2015-05-19
- Last updated
- 2018-05-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02448550. Inclusion in this directory is not an endorsement.